US › Healthcare

XWELL Inc. (XWEL)

US · Healthcare · Diagnostics & Research

$0.73-2.13%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$7.1M

Revenue YoY

-7.1%

Net profit

$-2.2M

EPS

$-0.26

Net margin

-31.3%

Key statistics

Market cap

$8.2M

Forward P/E

10.8

P/B

20.33

Book value

$-0.22

EPS (TTM)

$-5.24

52-week high

$2.20

52-week low

$0.26

50-day MA

$0.95

200-day MA

$0.99

Beta

0.94

Analyst view

with an average price target of $7.00.

Shareholding

Insiders

27.11%

Institutions

16.83%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	1.36%
Sontag Advisory LLC	1.22%
BlackRock Inc	0.95%
Geode Capital Management, LLC	0.65%
Vanguard Capital Management, LLC	0.60%
XTX Topco Ltd	0.38%
Jane Street Group LLC	0.36%
Vanguard Fiduciary Trust Co	0.27%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for XWELL Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.